A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics
Clinical trial NCT02752516 · UNKNOWN
Trial details
- NCT number
- NCT02752516
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-27
- Primary completion
- 2017-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.